Filing Flows › Health Care › Stemtech (STEK)
Stemtech (STEK) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · Stemtech (STEK) Q2 2026 earnings results →
Q2 2026 Revenue down 10% year over year to $629K · 46¢ of every $1 of revenue lost · operating margin -20.0%
Stemtech made $629K in Q2 2026 (-10% Y/Y). Operating margin -20.0%, net loss $292K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $629K in Q2 2026, down 10% year over year and up 36% from the previous quarter.
Gross margin was 74.0%, down 5.1 points from Q2 2025. Operating costs exceeded revenue by $126K, an operating margin of -20.0%. Operating expenses fell 31% while revenue fell 10%. The quarter ended with a net loss of $292K, narrower than the previous quarter's $1.3M loss. Net interest and other expense of $167K was the main reason.
Operating cash flow was −$55K. Non-cash charges added back $42K of depreciation and amortization and $109K of share-based compensation. Working capital and other items added $86K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $629K | -10% | -20.0% | −$292K | −$55K |
| Q1 2026 | 10-Q | Jun 22, 2026 | $463K | -47% | -236.4% | −$1.3M | −$426K |
| Q4 2025 | 10-K | May 29, 2026 | $458K | -65% | -188.6% | −$1.5M | $127K |
| Q3 2025 | 10-Q | Nov 19, 2025 | $852K | -17% | -39.8% | −$813K | $25K |
| Q2 2025 | 10-Q | Aug 19, 2025 | $698K | -47% | -43.1% | −$296K | $75K |
| Q1 2025 | 10-Q | Jul 17, 2025 | $868K | -37% | -138.8% | −$1.5M | −$711K |
| Q4 2024 | 10-K | Jun 30, 2025 | $1.3M | -4% | 2.5% | −$397K | −$271K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Stemtech
Stemtech Corporation and its Subsidiaries (collectively, the “Company”, or “Stemtech”) was incorporated in the State of Nevada, USA on September 4, 2009 under the name Globe Net Wireless Corp. with ticker symbol “GNTW”. Our corporate name was changed to Stemtech Corporation in the state of Nevada in August 2021. On August 19, 2021, Stemtech Corporation, a Delaware corporation (the “accounting acquirer”), completed a reverse merger with Globe Net Wireless Corp., the Nevada legal registrant and continuing SEC reporting entity. The historical financial statements presented reflect the operations of Stemtech Corporation (Delaware) as the accounting acquirer for financial reporting purposes. We were listed on the OTCQB market under symbol “STEK” in April 2021.
In its own words, from its 10-Q, filed Aug 14, 2026.
Stemtech against its Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -10% against the peers' median +5%. Operating margin: -20.0% against the peers' median 1.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| STEK Stemtech | Q2 2026 | $629K | -10% | -20.0% |
| MCK McKesson | Q2 FY27 | $111.0B | +8% | 1.4% |
| COR Cencora | Q3 FY26 | $84.8B | +5% | 1.3% |
| CAH Cardinal Health | Q1 FY27 | $67.5B | +6% | 1.1% |
| HLF Herbalife | Q3 2026 | $1.4B | +6% | 10.3% |
| NUS Nu Skin Enterprises | Q3 2026 | $311M | -15% | 1.6% |
| COSM Cosmos Health | Q2 2026 | $19.0M | +29% | -15.4% |
| MEDS DataMeds AI | Q2 2026 | $1.8M | -77% | -412.7% |
| ESYN HWH International | Q2 2026 | $64K | -79% | 328.1% |
Source: Stemtech 10-Q on SEC EDGAR · CIK 1511820 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
More on STEK
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results